• 1
    Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. Eur. J. Cancer 2001; 37 (Suppl. 8): 466.
  • 2
    Breslow N, Chan CW, Dhom G et al. Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer 1977; 20: 6808.
  • 3
    Akazaki K, Stemmermann GN. Compararative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J. Natl Cancer Inst. 1973; 50: 113744.
  • 4
    Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H. Trends and characteristics in prostate cancer mortality in Japan. Int. J. Urol. 2000; 7: 2547.
  • 5
    Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I. International comparisons. BJU Int. 2002; 90: 16273.
  • 6
    Parkin DM, Pisani P, Ferlay J. Estimates of the world-wide incidence of 25 major cancers in 1990. Int. J. Cancer 1999; 80: 82741.
  • 7
    Coleman MP, Esteve J, Damieki P et al. Trends in Cancer Incidence and Mortality. IARC. Scientific Publications no. 121. International Agency for Research on Cancer, Lyons, 1993.
  • 8
    Whittlemore AS. Trends in Cancer Incidence and Mortality. Cancer Surveys , Vol. 19, 20. Imperial Cancer Research Fund/Cold Spring Harbor Laboratory Press, New York, 1994.
  • 9
    The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1997: estimates based on data from 12 population-based cancer registries. Jpn J. Clin. Oncol. 2002; 32: 31822.
  • 10
    Japanese Urological Association and The Japanese Society of Pathology. General Rule for Clinical and Pathological Studies on Prostate Cacner. Kanehara, Tokyo, 2001.